Potente, M., Gerhardt, H. & Carmeliet, P. Basic and therapeutic aspects of angiogenesis. Cell 146, 873–887 (2011).
Article CAS PubMed Google Scholar
Kuczynski, E. A., Vermeulen, P. B., Pezzella, F., Kerbel, R. S. & Reynolds, A. R. Vessel co-option in cancer. Nat. Rev. Clin. Oncol. 16, 469–493 (2019).
Article CAS PubMed Google Scholar
Petrova, T. V. & Koh, G. Y. Biological functions of lymphatic vessels. Science 369, eaax4063 (2020).
Article CAS PubMed Google Scholar
Goldmann, E. The growth of malignant disease in man and the lower animals, with special reference to the vascular system. Proc. R. Soc. Med. 1, 1–13 (1908).
CAS PubMed PubMed Central Google Scholar
Ribatti, D., Vacca, A. & Dammacco, F. The role of the vascular phase in solid tumor growth: a historical review. Neoplasia 1, 293–302 (1999).
Article CAS PubMed PubMed Central Google Scholar
Ide, A. G., Baker, N. H. & Warren, S. L. Vascularization of the Brown–Pearce rabbit epithelioma transplant as seen in the transparent ear chambers. Am. J. Roentgenol. 32, 891–899 (1939).
Algire, G. H. & Chalkley, H. W. Vascular reactions of normal and malignant tissue in vivo. J. Natl Cancer Inst. 6, 73–85 (1945).
Greenblatt, M. & Shubi, P. Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. J. Natl Cancer Inst. 41, 111–124 (1968).
Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182–1186 (1971).
Article CAS PubMed Google Scholar
Gimbrone, M. A.Jr, Leapman, S. B., Cotran, R. S. & Folkman, J. Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 136, 261–276 (1972).
Article PubMed PubMed Central Google Scholar
Kim, K. J. et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841–844 (1993).
Article CAS PubMed Google Scholar
Grunstein, J., Roberts, W. G., Mathieu-Costello, O., Hanahan, D. & Johnson, R. S. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 59, 1592–1598 (1999).
Yang, J. C. et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. N. Engl. J. Med. 349, 427–434 (2003).
Article CAS PubMed PubMed Central Google Scholar
Hurwitz, H. et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350, 2335–2342 (2004).
Article CAS PubMed Google Scholar
Sandler, A. et al. Paclitaxel–carboplatin alone or with bevacizumab for non-small-cell lung cancer. N. Engl. J. Med. 355, 2542–2550 (2006).
Article CAS PubMed Google Scholar
Boehm, T., Folkman, J., Browder, T. & O’Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390, 404–407 (1997).
Article CAS PubMed Google Scholar
Jayson, G. C., Kerbel, R., Ellis, L. M. & Harris, A. L. Antiangiogenic therapy in oncology: current status and future directions. Lancet 388, 518–529 (2016).
Article CAS PubMed Google Scholar
Cao, Y., Langer, R. & Ferrara, N. Targeting angiogenesis in oncology, ophthalmology and beyond. Nat. Rev. Drug Discov. 22, 476–495 (2023).
Article CAS PubMed Google Scholar
Folkman, J., Watson, K., Ingber, D. & Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58–61 (1989).
Article CAS PubMed Google Scholar
Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364 (1996).
Article CAS PubMed Google Scholar
Bergers, G. & Benjamin, L. E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3, 401–410 (2003).
Article CAS PubMed Google Scholar
Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
Article CAS PubMed Google Scholar
Hanahan, D. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315, 115–122 (1985).
Article CAS PubMed Google Scholar
Smith-McCune, K., Zhu, Y. H., Hanahan, D. & Arbeit, J. Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. Cancer Res. 57, 1294–1300 (1997).
Consolino, L. et al. Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging. Int. J. Cancer 139, 404–413 (2016).
Article CAS PubMed Google Scholar
Guidi, A. J., Fischer, L., Harris, J. R. & Schnitt, S. J. Microvessel density and distribution in ductal carcinoma in situ of the breast. J. Natl Cancer Inst. 86, 614–619 (1994).
Article CAS PubMed Google Scholar
Smith-McCune, K. K. & Weidner, N. Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res. 54, 800–804 (1994).
Hlatky, L., Hahnfeldt, P. & Folkman, J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J. Natl Cancer Inst. 94, 883–893 (2002).
De Palma, M., Biziato, D. & Petrova, T. V. Microenvironmental regulation of tumour angiogenesis. Nat. Rev. Cancer 17, 457–474 (2017).
Senger, D. R. et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983–985 (1983).
Article CAS PubMed Google Scholar
Ferrara, N. & Henzel, W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161, 851–858 (1989).
Article CAS PubMed Google Scholar
Keck, P. J. et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309–1312 (1989).
Article CAS PubMed Google Scholar
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V. & Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306–1309 (1989).
留言 (0)